Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Researchers
Kuwait
Medical specialists from Kuwait tagged by Regulatory Authorities as investigators in clinical studies for the listed conditions:
A
Airway Obstruction
Angioedema
Angioedemas, Hereditary
C
COVID-19
Carcinoma
Cerebral Palsy
D
Diabetes Mellitus
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
F
Fatty Liver
G
Gastrointestinal Hemorrhage
Glucose Intolerance
H
Hemorrhage
Hereditary Angioedema
L
Liver Diseases
M
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Muscle Weakness
N
Nasopharyngeal Carcinoma
Neurodevelopmental Disorders
Non-alcoholic Fatty Liver Disease
P
Paresis
Pneumonia
Pneumonia, Viral
Prediabetic State
R
Respiratory Insufficiency
S
Sclerosis
Sponsors and Collaborators
National Institute for Health Research Nottingham Biomedical Research Centre
Beijing Sino-Japan Friendship Hospital
Dr. Wolfgang Senker
Adjuvance Technologies, Inc.
BlueWillow Biologics
No.3 People's Hospital of Chengdu
Beijing Chaoyang District Third Hospital
CHU of Saint Etienne: French Ministry of Health Grant (sponsor of the French part of the study)
Virender S Sangwan, MBBS, MS
Vibeke Moen
Sikkim Manipal University
Centre for Research in Intensive Care (CRIC)
The PLA Navy Anqing Hospital
EnGeneIC Limited
Yang Jianjun, PhD
Red Cross Copenhagen
International Psychoanalytic Association (IPA)
Sensible Medical Innovations Ltd.
Dr. Daniela LAUX, Paris
Piedmont Healthcare
View Full List
Medical Conditions
Osgood-Schlatter Disease
Second- or Third-degree Burns
Rotator Cuff Tear Surgical Repair
Stage IV Soft Tissue Sarcoma
Vascular Aging
Statins
Metastatic HER2+ Advanced Breast Cancer
FAP-Familial Adenomatous Polyposis
TAP Block
Intermittent Urethral Catheterization
Prosthetic Tissue Defect
AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
Hepatitis C, Chronic; AUD
Hepatitis C, Treatment Naïve, Genotype 1 Patients
Cardiac Arrest Survivors
Mobile Application Based Learning
Dental Atraumatic Restorative Treatment
Neoadjuvant or Conversion Therapy
CIP
View Full List
Drug Interventions
Chidamide
Ibuprofen
DW6012
CCS1477
FOLFOX
Pentoxifylline
Estradiol
Aripiprazole Lauroxil
Single corticosteroid inhalers and Singulair
Glucose
Topiramate
Efalizumab
PROMETRIUM® 400 mg
Aspirin 650mg Oral Capsule
Tarceva (Erlotinib Hydrochloride)
Venlafaxine 25 mg Tablets
Loxoprofen
IMC-F106C
Fesoterodine
Irinotecan liposome injection
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Gambia
Contract Research Organizations in Greece
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Mali
Contract Research Organizations in Norway
Contract Research Organizations in Pakistan
Contract Research Organizations in Paraguay
Contract Research Organizations in Slovakia
Contract Research Organizations in Slovenia
Contract Research Organizations in Suriname
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Algeria
Nagy Research
Axelys Sante
SGS
Clinica Group
All CROs in Algeria
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe